Now that February is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in January – they’re ranked in order of popularity, with number one being the most viewed piece. [Guide] 2018 Pharmaceutical And Medical […]
Posts Tagged ‘drugs’
How Pharma Is Tackling Drug Abuse
Our country is in the midst of an opioid epidemic. We are seeing staggering statistics of drug abuse, not to mention graphic images and videos of the effects drugs are having on families and their loved ones. While the FDA has taken a serious stance in the fight against drug abuse and has even come […]
How Many Novel Drugs Were Approved In 2017?
When it comes to drug approvals, 2017 was a great year for the pharmaceutical industry. According to Reuters, the number of drugs approved in the United States was the highest number in 21 years. In fact, the 46 novel drugs that were approved was more than double what was approved in 2016. This figure doesn’t […]
GlaxoSmithKline’s CEO Sums Up Today’s Pharma Landscape
When discussing the impact the United States’ new administration may have on pharmaceutical companies, GlaxoSmithKline’s Andrew Witty may have said it best: “I’ve had 30 years in this industry, and there’s never been a dull year. And there’s never been a year where it hasn’t felt challenging and interesting. And I suspect the next 30 years won’t be […]
10 Headlines That Suggest Donald Trump Is Good For Pharma
This year’s presidential election invoked serious fear in the pharmaceutical industry, with the cost of drugs taking center stage for a good portion of some candidates’ campaigns. While what candidates say they’ll do could very well be different than what they’ll try to do, their words and records are enough to push pundits, investors, and […]
How Jazz Uses Connected Health To Create Awareness And Demand
A recent conversation with a prospective client of ours prompted me to write this post. The client is looking at ways to improve the adoption rate of one of its products by a specific population because, for a variety of reasons, adoption by that segment has been slower than others. The solution to challenges like […]
Companion Diagnostics and Pharmaceuticals: Tying The Knot
I recently read an article, The Future of Cancer Treatment Is (Almost) Here, which discusses liquid biopsy, a method of using blood samples to detect cancer. While new forms of cancer detection and monitoring continue to be developed, we’ve already made significant strides in the treatment of certain diseases.
How Insurance Companies Decide Which Drugs To Cover
It’s no secret that certain drugs cost a lot of money. And, naturally, pharmacy benefit managers (PBMs), the ones who really decide which drugs insurance companies cover, don’t like it. Their answer? Move to a lower cost drug. But, if it’s the only drug of its kind, they’re stuck covering it for you…that is, until […]